TRANSPLANTS FOR CHRONIC MYELOID-LEUKEMIA (CML) IN CHRONIC PHASE (CP) - THE EFFECT OF AGE

被引：0
|
作者：
PETERSEN, FB [1 ]
CLIFT, RA [1 ]
BUCKNER, CD [1 ]
机构：
[1] SEATTLE MARROW TRANSPLANT TEAM,SEATTLE,WA
来源：
EXPERIMENTAL HEMATOLOGY | 1991年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [1] The influence of patient age on the outcome of transplantation during chronic phase (CP) of chronic myeloid leukemia (CML).
    Clift, RA
    Buckner, CD
    Storb, R
    Appelbaum, FR
    Thomas, ED
    BLOOD, 1995, 86 (10) : 2457 - 2457
  • [2] CHRONIC MYELOID-LEUKEMIA (CML) - A THERAPEUTIC DILEMMA
    ROZMAN, C
    CARRERAS, E
    MEDICINA CLINICA, 1995, 105 (01): : 24 - 26
  • [3] OSTEOLYTIC LESIONS IN CHRONIC MYELOID-LEUKEMIA (CML)
    PIERA, JJ
    MEDICINA CLINICA, 1983, 80 (11): : 513 - 513
  • [4] CYTOGENETIC STAGING OF CHRONIC MYELOID-LEUKEMIA (CML)
    SANDBERG, AA
    BOLLETTINO DELL ISTITUTO SIEROTERAPICO MILANESE, 1978, 57 (03): : 247 - 256
  • [5] Study of tumor cells immunophenotype in chronic phase (CP) of chronic myeloid leukemia (CML).
    Logacheva, NP
    Turkina, AG
    Shishkin, YV
    Zabotina, TN
    Baryshnikov, AY
    LEUKEMIA, 2001, 15 (03) : 504 - 504
  • [6] CHROMOSOMAL FINDINGS IN RELATION TO BLASTIC PHASE OF CHRONIC MYELOID-LEUKEMIA (CML)
    SANDBERG, AA
    SONTA, S
    BOLLETTINO DELL ISTITUTO SIEROTERAPICO MILANESE, 1978, 57 (03): : 334 - 343
  • [7] RISK-FACTORS FOR RELAPSE AFTER BMT FOR CHRONIC MYELOID-LEUKEMIA (CML) IN 1ST CHRONIC PHASE (CP)
    APPERLEY, JF
    MAURO, F
    GOLDMAN, JM
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 535 - 535
  • [8] MOLECULAR-BIOLOGY OF CHRONIC MYELOID-LEUKEMIA (CML)
    GOLDMAN, JM
    ACTA HAEMATOLOGICA, 1987, 78 : 200 - 200
  • [9] Ponatinib As Initial Therapy For Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP)
    Cortes, Jorge E.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Daver, Naval
    Quintas-Cardama, Alfonso
    Ravandi, Farhad
    Gachimova, Evguenia
    Estrov, Zeev
    Jabbour, Elias
    O'Brien, Susan
    Kantarjian, Hagop
    BLOOD, 2013, 122 (21)
  • [10] Ponatinib As Frontline Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
    Jain, Preetesh
    Kantarjian, Hagop M.
    Jabbour, Elias
    Borthakur, Gautam
    Pemmaraju, Naveen
    Daver, Naval
    Gachimova, Evguenia
    Ferrajoli, Alessandra
    Kornblau, Steven M.
    Ravandi, Farhad
    O'Brien, Susan
    Cortes, Jorge E.
    BLOOD, 2014, 124 (21)
12345